CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

INTSINTENSITY THERAPEUTICS, INC.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $3.37 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$11.00M
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-01 · Wesolowski John M (Principal Accounting Officer) · OTHER
  • 2026-07-01 · Talamo Joseph (Chief Financial Officer) · OTHER
  • 2026-03-30 · BENDER LEWIS H (President and CEO) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders21
Shares held1,854,143
Value$5.07M
Percent of shares outstanding56.79%
As of quarter end2026-06-30
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
INTENSITY THERAPEUTICS, INC. (INTS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit